Virax Biolabs Group Ltd Cash Flows From Used In Financing Activities
Virax Biolabs Group Ltd (VRAX) reported Cash Flows From Used In Financing Activities of $5.81 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-07-02
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-03-31 | $5.81M 20-F · filed 2025-07-02 |
| 2024-03-31 | $1.65M 20-F · filed 2025-07-02 |
| 2023-03-31 | $13.69M 20-F · filed 2025-07-02 |
| 2022-03-31 | $813.21K 20-F · filed 2024-08-20 |
| 2021-03-31 | $585.20K 20-F · filed 2022-08-12 |